Harpoon Therapeutics, Inc.
HARPNASDAQHealthcare
$23.01
+$0.02(+0.09%)
Market Cap$865079358
P/E Ratio—
52W High$23.21
52W Low$3.11
Harpoon Therapeutics, Inc. (HARP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HARP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $31.91M | $23.65M | $17.44M | $5.78M | $4.75M |
| Cost of Revenue | $3.10M | $2.65M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $28.82M | $21.01M | $17.44M | $5.78M | $4.75M |
| Gross Margin %(computed) | 90.30% | 88.81% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $81.39M | $72.12M | $52.56M | $41.59M | $26.37M |
| G&A Expenses | $18.85M | $18.33M | $16.21M | $22.39M | $6.11M |
| Total Operating Expenses | $100.24M | $90.45M | $68.78M | $63.98M | $32.47M |
| Operating Income | ($68.33M) | ($116.75M) | ($51.33M) | ($58.21M) | ($27.72M) |
| Operating Margin %(computed) | -214.08% | -493.58% | -294.26% | — | -583.66% |
| Interest Income | $0.78M | $0.24M | $1.45M | $2.68M | $0.40M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($67.73M) | ($116.72M) | ($49.91M) | ($55.57M) | ($27.37M) |
| Income Tax Expense | ($0.59M) | $49.71M | ($3.53M) | ($3.58M) | $0.00M |
| Net Income | ($67.14M) | ($166.44M) | ($46.38M) | ($52.00M) | ($27.37M) |
| Net Margin %(computed) | -210.36% | -703.62% | -265.86% | -900.05% | -576.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-20.24 | $-51.57 | $-18.52 | $-23.91 | $-11.45 |
| Wtd Avg Shares | 3.32M | 3.23M | 2.50M | 2.17M | 2.39M |
| EBITDA | ($65.97M) | ($14.65M) | ($49.25M) | ($58.21M) | ($27.37M) |
| EBITDA Margin %(computed) | -206.70% | -61.95% | -282.33% | — | -576.13% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Harpoon Therapeutics, Inc. data
About Harpoon Therapeutics, Inc. (HARP) Income Statement
Harpoon Therapeutics, Inc. (HARP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, HARP reported revenue of $0.03B, gross profit of $0.03B (gross margin 90.30%), and net income of ($0.07B) — a net profit margin of -210.36%.
Frequently asked questions
HARP · 4 questionsHarpoon Therapeutics, Inc. (HARP) reported revenue of $0.03B for 2022, up 34.9% year-over-year.
HARP revenueHARP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09